Page results
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Patient information on managing pain
-
UCLH vision, values and strategy
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Bones marrow harvest patient information page.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
File results
-
FOI/2021/0749 - Private contractors
-
FOI/2021/0751 - TB Find and Treat programme
-
FOI/2022/0002 - Patient Portal / Patient Access Portal system
-
FOI/2022/0007 - Priory Group services at the Trust
-
FOI/2022/0008 - Functional electrical stimulation devices
-
FOI/2022/0012 - Paediatric antibiotic guideline
-
FOI/2022/0014 - Water treatment equipment in sterile services department
-
FOI/2022/0042 - Thermometers used at Trust
-
FOI/2022/0023 - Assault attendances to ED
-
FOI/2022/0026 - Patients referred for puberty blockers/ services related to gender identity